Plain-English translation of NCT07519044 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
When you have a large clot blocking blood flow in your brain, doctors use a procedure called mechanical thrombectomy to remove it. Even after successful clot removal, some patients don't recover as well as hoped because the brain tissue can still be damaged. This trial is testing whether adding a medication called GM1—which is designed to protect brain cells from damage—can improve recovery when given alongside the clot removal procedure.
While mechanical thrombectomy successfully opens blocked blood vessels in most patients, fewer than half achieve good long-term recovery because the brain can still suffer damage during and after the procedure. This medication may protect brain cells and help prevent this damage, but it has not yet been tested specifically in patients undergoing clot removal surgery.
You likely qualify if…
You likely don't qualify if…
You will receive emergency clot removal surgery as planned. During or shortly after the procedure, you will be randomly assigned to receive either the protective medication or a placebo (inactive treatment) through an IV. You'll then be followed closely in the hospital and return for a follow-up visit 90 days after your stroke to assess your recovery. The study involves standard stroke care plus this additional medication or placebo.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
China